Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MSA vs RBOT.WS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MSA Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 10–0 Matrix Metrics)

MSA Overall Winner 6-Pillar Tally: MSA 5 – 0 RBOT.WS (1 Tie) Matrix Metrics: MSA 10 – 0 RBOT.WS

As of Nov 20, 2026, Mine Safety Incorporated (MSA) is the stronger overall head-to-head candidate over Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of (RBOT.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MSA carries a Unified Composite Score of 55.4/100 (HOLD) at $170.03 (17.1x Forward P/E, 23.0% operating margin), whereas RBOT.WS carries 50.1/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: MSA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile RBOT.WS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MSA vs RBOT.WS
MSA NYSE Head-to-Head Winner
Mine Safety Incorporated
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$170.03
-3.52% 1D
Market Cap $6.8B
TTM Revenue $2.01B
Forward P/E 17.1x
Beta / 30D Vol 0.75β · 38% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 59.0 Fund 54.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 41
RSI-14: 41.3 · SMA20: $175.76 · SMA50: $178.77
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol N/A
Unified Composite Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (MSA 5 – 0 RBOT.WS)

Columns: Metric · MSA · RBOT.WS
1. Valuation Multiples MSA
Forward P/E 17.1x N/M
Trailing P/E 22.6x N/M
PEG Ratio 0.99x N/M
EV / Revenue 3.4x N/M
2. Growth & Scale MSA
Revenue Growth (YoY) +14.5% N/A
Earnings Growth (YoY) -14.7% N/A
TTM Revenue (USD) $2.01B N/A
Market Cap $6.8B N/A
3. Profitability & Quality MSA
Gross Margin 47.3% N/A
Operating Margin 23.0% N/A
Net Profit Margin 15.0% N/A
Return on Equity (ROE) 22.1% N/A
4. Balance Sheet & Cash Flow MSA
Cash Generation (TTM) $530M EBITDA N/A
Cash Flow Margin 26.3% EBITDA Mgn N/A
Net Cash / Leverage $37.12 Book/Sh · 22.1% ROE N/A ROE
Dividend Yield 1.21% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 24.5% (6th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat MSA
OpEx & R&D Intensity 24.3% of Rev ($489M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Security & Protection Services Operator Orthopedic, Prosthetic & Surgical Appliances & Supplies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MSA (10) vs RBOT.WS (0)
Institutional Metric MSA RBOT.WS Criterion Row Edge
Market Capitalization
Scale
$6.8B N/A Larger Scale MSA
Trailing P/E Ratio
Valuation
22.6x N/M Lower Multiple MSA
Forward P/E Ratio
Valuation
17.1x N/M Lower Multiple MSA
Revenue Growth (YoY)
Growth
+14.5% N/A Higher Growth MSA
Operating Margin (TTM)
Profitability
23.0% N/A Higher Margin MSA
Net Profit Margin
Profitability
15.0% N/A Higher Margin MSA
Return on Equity (ROE)
Capital Efficiency
22.1% N/A Higher ROE MSA
52-Week Range Position
Momentum
31% ($153–$209) 0% ($0–$0) Stronger Trend MSA
Beta / 30D Volatility
Risk Regime
0.75β · 38% Vol N/A Lower Realized Risk MSA
Unified Institutional Score
Composite Signal
55.4 / 100 (HOLD) 50.1 / 100 (HOLD) Higher Composite MSA
Trailing 12M Revenue (USD)
Operating Scale
$2.01B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.99x PEG · 3.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$530M EBITDA ($37.12 Book/Sh · 22.1% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MSA +72.16 pp
MSA: +4.96% · RBOT.WS: -67.2%
3M Horizon MSA +72.16 pp
MSA: +4.96% · RBOT.WS: -67.2%
6M Horizon MSA +72.16 pp
MSA: +4.96% · RBOT.WS: -67.2%
1Y Horizon MSA +72.16 pp
MSA: +4.96% · RBOT.WS: -67.2%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MSA vs RBOT.WS. Trailing 12-month operating profitability (MSA 23.0% vs RBOT.WS N/A) and valuation multiples (MSA 17.1x vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MSA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.01B
Gross Margin47.3%
Op. Margin23.0%
ROE / Fwd P/E22.1% · 17.1x
RBOT.WS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MSA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.5%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MSA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RBOT.WS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RBOT.WS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MSA Moat Profile Scale & Operating Efficiency Moat
Security & Protection Services Operator
Competes within the Security & Protection Services value chain with $6.8B market capitalization and 23.0% operating margin.
OpEx & R&D Reinvestment 24.3% of Rev ($489M)
90D Engineering Disclosures 0 Published
RBOT.WS Moat Profile Cyclical / Execution-Driven Positioning
Orthopedic, Prosthetic & Surgical Appliances & Supplies Operator
Competes within the Orthopedic, Prosthetic & Surgical Appliances & Supplies value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MSA vs RBOT.WS Key Questions & Quantitative Answers

As of Nov 20, 2026, Mine Safety Incorporated (MSA) is the stronger overall head-to-head candidate over Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of (RBOT.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MSA carries a Unified Composite Score of 55.4/100 (HOLD) at $170.03 (17.1x Forward P/E, 23.0% operating margin), whereas RBOT.WS carries 50.1/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: MSA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile RBOT.WS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MSA leads the Growth & Scale pillar: MSA posts +14.5% YoY revenue growth and -14.7% YoY earnings growth on $2.01B TTM revenue (47.3% gross margin, 23.0% operating margin), compared with RBOT.WS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MSA generates $2.01B in USD-normalized revenue versus N/A for RBOT.WS. In operating R&D and SG&A reinvestment, MSA deploys 24.3% of Rev ($489M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for RBOT.WS.

MSA screens cheaper on headline valuation multiples. MSA trades at 17.1x Forward P/E, 22.6x Trailing P/E, 0.99x PEG, and 3.4x EV/Revenue (26.3% EBITDA margin), whereas RBOT.WS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MSA (22.1% ROE) versus RBOT.WS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MSA carries 24.5% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.75β · 38% Vol realized risk). By comparison, RBOT.WS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00 (RBOT.WS) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.